Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines

Hiromasa Tsuiki, Masayuki Nitta, Mitsuhiro Tada, Masaki Inagaki, Yukitaka Ushio, Hideyuki Saya

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Checkpoint mechanism plays a crucial role in ensuring genomic integrity during cell cycle. Loss of checkpoint function is known to induce genomic instability and to alter ploidy of dividing cells. In this study, we examined mechanisms of hyperploid formation in glioma cells by treatment with nocodazole, which activates spindle assembly checkpoint by inhibiting microtubule polymerization. By prolonged nocodazole treatment, U251MG human glioma cell, which has a p53 mutation, underwent transient arrest at mitosis, and subsequently exited from mitotic arrest (termed 'mitotic slippage') followed by DNA replication without cytokinesis, resulting in hyperploid formation. Additionally, the heterogeneity in the number of centrosomes per cell increased during the hyperploid formation, suggesting that these hyperploid cells have genomic instability. By employing LN382 glioma cell that has a temperature-sensitive p53 mutation, we found that the activation of p53 prevents hyperploid formation after the prolonged nocodazole treatment. Furthermore, staurosporine, an inhibitor for a broad range of serine/threonine kinases including cdc2, was found to enhance hyperploid formation in U251MG cells by accelerating the induction of mitotic slippage. Interestingly, inhibitors specific for cdc2 kinase prevented the G2 to M transition but did not accelerate mitotic slippage, suggesting that staurosporinesensitive kinases other than cdc2 are required for maintenance of spindle assembly checkpoint. Moreover, the enhancement of hyperploid formation by staurosporine was also blocked by p53-dependent G1 checkpoint. These results suggest that abrogation of G1 checkpoint is a critical factor for formation of hyperploid cells after the mitotic slippage.

Original languageEnglish
Pages (from-to)420-429
Number of pages10
JournalOncogene
Volume20
Issue number4
DOIs
Publication statusPublished - 2001 Jan 25
Externally publishedYes

Fingerprint

Glioma
Microtubules
Cell Line
Nocodazole
Pharmaceutical Preparations
M Phase Cell Cycle Checkpoints
Staurosporine
Genomic Instability
Phosphotransferases
Centrosome
Mutation
Cytokinesis
Ploidies
Protein-Serine-Threonine Kinases
DNA Replication
Mitosis
Polymerization
Cell Cycle
Maintenance
Temperature

Keywords

  • Glioma
  • Hyperploidy
  • Microtubule inhibitor
  • Spindle assembly checkpoint
  • Staurosporine

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines. / Tsuiki, Hiromasa; Nitta, Masayuki; Tada, Mitsuhiro; Inagaki, Masaki; Ushio, Yukitaka; Saya, Hideyuki.

In: Oncogene, Vol. 20, No. 4, 25.01.2001, p. 420-429.

Research output: Contribution to journalArticle

Tsuiki, Hiromasa ; Nitta, Masayuki ; Tada, Mitsuhiro ; Inagaki, Masaki ; Ushio, Yukitaka ; Saya, Hideyuki. / Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines. In: Oncogene. 2001 ; Vol. 20, No. 4. pp. 420-429.
@article{7cd2c8ce139c4ac1b16190498acdaccd,
title = "Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines",
abstract = "Checkpoint mechanism plays a crucial role in ensuring genomic integrity during cell cycle. Loss of checkpoint function is known to induce genomic instability and to alter ploidy of dividing cells. In this study, we examined mechanisms of hyperploid formation in glioma cells by treatment with nocodazole, which activates spindle assembly checkpoint by inhibiting microtubule polymerization. By prolonged nocodazole treatment, U251MG human glioma cell, which has a p53 mutation, underwent transient arrest at mitosis, and subsequently exited from mitotic arrest (termed 'mitotic slippage') followed by DNA replication without cytokinesis, resulting in hyperploid formation. Additionally, the heterogeneity in the number of centrosomes per cell increased during the hyperploid formation, suggesting that these hyperploid cells have genomic instability. By employing LN382 glioma cell that has a temperature-sensitive p53 mutation, we found that the activation of p53 prevents hyperploid formation after the prolonged nocodazole treatment. Furthermore, staurosporine, an inhibitor for a broad range of serine/threonine kinases including cdc2, was found to enhance hyperploid formation in U251MG cells by accelerating the induction of mitotic slippage. Interestingly, inhibitors specific for cdc2 kinase prevented the G2 to M transition but did not accelerate mitotic slippage, suggesting that staurosporinesensitive kinases other than cdc2 are required for maintenance of spindle assembly checkpoint. Moreover, the enhancement of hyperploid formation by staurosporine was also blocked by p53-dependent G1 checkpoint. These results suggest that abrogation of G1 checkpoint is a critical factor for formation of hyperploid cells after the mitotic slippage.",
keywords = "Glioma, Hyperploidy, Microtubule inhibitor, Spindle assembly checkpoint, Staurosporine",
author = "Hiromasa Tsuiki and Masayuki Nitta and Mitsuhiro Tada and Masaki Inagaki and Yukitaka Ushio and Hideyuki Saya",
year = "2001",
month = "1",
day = "25",
doi = "10.1038/sj.onc.1204126",
language = "English",
volume = "20",
pages = "420--429",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines

AU - Tsuiki, Hiromasa

AU - Nitta, Masayuki

AU - Tada, Mitsuhiro

AU - Inagaki, Masaki

AU - Ushio, Yukitaka

AU - Saya, Hideyuki

PY - 2001/1/25

Y1 - 2001/1/25

N2 - Checkpoint mechanism plays a crucial role in ensuring genomic integrity during cell cycle. Loss of checkpoint function is known to induce genomic instability and to alter ploidy of dividing cells. In this study, we examined mechanisms of hyperploid formation in glioma cells by treatment with nocodazole, which activates spindle assembly checkpoint by inhibiting microtubule polymerization. By prolonged nocodazole treatment, U251MG human glioma cell, which has a p53 mutation, underwent transient arrest at mitosis, and subsequently exited from mitotic arrest (termed 'mitotic slippage') followed by DNA replication without cytokinesis, resulting in hyperploid formation. Additionally, the heterogeneity in the number of centrosomes per cell increased during the hyperploid formation, suggesting that these hyperploid cells have genomic instability. By employing LN382 glioma cell that has a temperature-sensitive p53 mutation, we found that the activation of p53 prevents hyperploid formation after the prolonged nocodazole treatment. Furthermore, staurosporine, an inhibitor for a broad range of serine/threonine kinases including cdc2, was found to enhance hyperploid formation in U251MG cells by accelerating the induction of mitotic slippage. Interestingly, inhibitors specific for cdc2 kinase prevented the G2 to M transition but did not accelerate mitotic slippage, suggesting that staurosporinesensitive kinases other than cdc2 are required for maintenance of spindle assembly checkpoint. Moreover, the enhancement of hyperploid formation by staurosporine was also blocked by p53-dependent G1 checkpoint. These results suggest that abrogation of G1 checkpoint is a critical factor for formation of hyperploid cells after the mitotic slippage.

AB - Checkpoint mechanism plays a crucial role in ensuring genomic integrity during cell cycle. Loss of checkpoint function is known to induce genomic instability and to alter ploidy of dividing cells. In this study, we examined mechanisms of hyperploid formation in glioma cells by treatment with nocodazole, which activates spindle assembly checkpoint by inhibiting microtubule polymerization. By prolonged nocodazole treatment, U251MG human glioma cell, which has a p53 mutation, underwent transient arrest at mitosis, and subsequently exited from mitotic arrest (termed 'mitotic slippage') followed by DNA replication without cytokinesis, resulting in hyperploid formation. Additionally, the heterogeneity in the number of centrosomes per cell increased during the hyperploid formation, suggesting that these hyperploid cells have genomic instability. By employing LN382 glioma cell that has a temperature-sensitive p53 mutation, we found that the activation of p53 prevents hyperploid formation after the prolonged nocodazole treatment. Furthermore, staurosporine, an inhibitor for a broad range of serine/threonine kinases including cdc2, was found to enhance hyperploid formation in U251MG cells by accelerating the induction of mitotic slippage. Interestingly, inhibitors specific for cdc2 kinase prevented the G2 to M transition but did not accelerate mitotic slippage, suggesting that staurosporinesensitive kinases other than cdc2 are required for maintenance of spindle assembly checkpoint. Moreover, the enhancement of hyperploid formation by staurosporine was also blocked by p53-dependent G1 checkpoint. These results suggest that abrogation of G1 checkpoint is a critical factor for formation of hyperploid cells after the mitotic slippage.

KW - Glioma

KW - Hyperploidy

KW - Microtubule inhibitor

KW - Spindle assembly checkpoint

KW - Staurosporine

UR - http://www.scopus.com/inward/record.url?scp=0035945637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035945637&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1204126

DO - 10.1038/sj.onc.1204126

M3 - Article

C2 - 11313973

AN - SCOPUS:0035945637

VL - 20

SP - 420

EP - 429

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 4

ER -